Immunovant, Inc. (IMVT)
31.20
-0.40
(-1.28%)
USD |
NASDAQ |
Jun 10, 16:00
31.20
0.00 (0.00%)
After-Hours: 18:44
Immunovant Shareholders Equity (Quarterly) : 852.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 852.59M |
| December 31, 2025 | 986.14M |
| September 30, 2025 | 519.70M |
| June 30, 2025 | 608.54M |
| March 31, 2025 | 707.45M |
| December 31, 2024 | 352.62M |
| September 30, 2024 | 449.05M |
| June 30, 2024 | 544.66M |
| March 31, 2024 | 617.76M |
| December 31, 2023 | 679.34M |
| September 30, 2023 | 251.81M |
| June 30, 2023 | 299.86M |
| March 31, 2023 | 362.49M |
| Date | Value |
|---|---|
| December 31, 2022 | 414.68M |
| September 30, 2022 | 395.75M |
| June 30, 2022 | 436.49M |
| March 31, 2022 | 469.82M |
| December 31, 2021 | 505.15M |
| September 30, 2021 | 536.40M |
| June 30, 2021 | 365.53M |
| March 31, 2021 | 391.48M |
| December 31, 2020 | 414.15M |
| September 30, 2020 | 438.41M |
| June 30, 2020 | 267.78M |
| March 31, 2020 | 94.07M |
| December 31, 2019 | 111.86M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Roivant Sciences Ltd. | 4.527B |
| Summit Therapeutics, Inc. | 545.93M |
| Protagonist Therapeutics, Inc. | 655.47M |
| UroGen Pharma Ltd. | -124.25M |
| Cogent Biosciences, Inc. | 607.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 957.57M |
| Total Liabilities (Quarterly) | 104.98M |
| Debt to Equity Ratio | 0.0001 |
| Current Ratio | 9.086 |
| Net Debt Paydown Yield | -0.00% |